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Summary 
Monoclonal antibodies (mAbs) have been made specific for the pre-B cell-specific proteins Vp~,B 
and,),s  which together form the surrogate light (L) chain,  mAbs specific for Vvr,B protein 
identified the 16-kD molecule associated on precursor B cell lines with ),s protein as the product 
of the Vp~B gene. Surrogate L chain was detectable even in the absence of #  heavy (H) chain 
on the surface of early precursor cell lines such as pro-B cell lines where all immunoglobulin 
(Ig) loci are in the germline configuration, as well as early pre-B cell lines where Ig H  chain 
loci are DaJ. rearranged in reading frame I or III, which does not allow the expression of a 
D,J.C# protein. A complex of glycoproteins (200,  130, 105, and 65-35 kD) was identified as 
coprecipitated with the Vp~b/),s surrogate L chain in # H chain-negative precursor B cell lines. 
The 130-kD  protein was most strongly labeled with iodine and most consistently detected in 
noncovalent association  with surrogate L  chain.  This protein turned out  to be a  N-linked 
glycoprotein with a 100-kD protein core and isoelectric point 5.8, indicating that it is distinct 
from CD43 and the BP-1/6C3 antigen. The surface deposition of the surrogate L chain in association 
with the newly identified glycoproteins suggests that the surrogate L chain may function as 
a receptor even before the association  with #  H  chain in early precursor B cells. 
T 
wo genes,  VpreB and ),s,  are transcribed selectively in 
precursor B cells (1-3). Mature B cells, Ig-secreting plasma 
cells, and any other cells in the body so far tested do not 
express these two genes.  The Vp~eB gene has sequence ho- 
mology to V regions of Ig H  and L chain genes,  whereas 
part  of the  )`s  gene displays  homology to  the J  and  C 
regions of the Ig )` L chain gene. Therefore, it was expected 
that  the Vm8 and Xs proteins might associate with each 
other to form an Ig L chainlike structure, the so-caUed sur- 
rogate L chain. It was further expected that the ),s protein 
of surrogate L chain could be disulfide linked via its penulti- 
mate cysteine at the COOH-terminal end to/~ H  chain to 
form an Ig-like complex. Indeed, the formation of such a 
/z H chain/Xs/Vw,B complex has been proven by gene trans- 
fection experiments (4,  5). 
Once the )`s and Vp~,B genes had been discovered,  two 
proteins called r  and ~  were found associated with # H chains 
on the surface of some pre-B call lines (6, 7). One of them 
(r  was shown to be the product of the )`s gene, and the 
other (0 was predicted to be the product of the Vp~,B gene 
(7). Subsequently, )`s protein was detected with polyclonal 
),s-specific antibodies on the surface of pre-B cell lines and 
bone marrow cells, although it remained to be proven that 
the 16-kD polypeptide coprecipitated with ),2 protein was, 
indeed, the product of the VmB gene (8,  9). 
The #  H chain/surrogate L chain complex expressed on 
pre-B cell lines has been found to transmit biochemical signals 
to the cells (9, 10), suggesting that this complex could func- 
tion as a receptor on the surface of pre-B cells. The impor- 
tant role of )`s protein in the B cell development was demon- 
strated by targeted disruption of the ),5 gene in the germline 
yielding a ),s-deficient  mutant mouse strain (11). In these 
mice, B cell development is impaired at the transition from 
pre-B I to pre-B II cells, resulting in a depletion of 95% of 
all CD45R(B200) + B cell precursors  in bone marrow and 
in a delayed appearance of CD5-  B cells in the peripheral 
lymphoid organs (11, 12). 
It has been shown that the 22-kD ),s protein and the 16- 
kD protein (p16)- presumed to be the Vpr~ protein--are ex- 
pressed together on the surface of# H chain-negative precursor 
B cell lines (9). This has raised the questions (a) is the p16 
identical to Vpr~ protein, and if so; (b) how can the VmB/Xs 
surrogate L chain be deposited in the surface membrane in 
the absence of/z H  chain? 
In this paper, we describe the generation of mAbs specific 
for the Vv~ protein or for ),s protein. We use them to study 
the synthesis, assembly, and surface membrane deposition of 
VmB/),5 surrogate L chain in a panel of precursor B cell 
lines.  We identify molecules that are  associated  with the 
VvreB/),S surrogate L chain and that might take the place of 
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yet express/~ H  chains. 
Materials  and Methods 
Cell Lines.  The origins and the state of Ig gene loci of pro- 
and pre-B cell lines used in this study are listed (see Table 1). The 
cell lines have been described as the following: 63-12 and 63-24 
(13); 38B9, 40E1, 204-1-8, 300-19P, 220-8, 28C9, and 204-3-1 (14, 
15); 18-81 (16); 70Z/3 (17); NFS5.3 (18); B3-P8-16-1-/~ (19); and 
38C13 (20). Clone 18, PAL1, and NP were established  as described 
(21, 22). B cell lymphoma cells used as control were IgM (/~, r)- 
expressing WEHI231 (23) and IgM (/~, X)-expressing CH-1 (24). 
All cell lines were maintained in IMDM supplemented with 10% 
FCS (Northumbria Biologicals  Ltd., Cramlington, UK), 100 U/ml 
of  penicillin-streptomycin  (Gibco Laboratories, Grand Island, NY), 
2 mM L-glutamine (Gibco Laboratories), and 5 x  10 -5 M 2-ME. 
Antibodies.  Rat mAbs used were M41 (IgG1) specific for mu- 
rine #  H chain (25), 187.1 (IgG1) specific for murine K L chain 
(26), R1-2 (IgG2b) specific for lymphocyte Peyer's  patch high en- 
dothelial venules (HEV) adhesion molecule 1 [LPAM-1] (routine 
very late antigen [VLA] 400 (27), M1/9.3.4 (IgG2a) specific for 
CD45 (28), and Strl0 (IgG) specific  for MHC dass I (tLolink A., 
unpublished observations). 
Vectors and  DNA  Transfection.  BCMGSHygXs and  BCM- 
GSHygVr,~ were constructed by insertion of Xs cDNA (1) or Vr~ 
cDNA (3), respectively, into the expression vector BCMGSHyg 
(4). Ig-nonproducing X63-Ag8.653 myeloma  cells (29) were trans- 
fected by  electroporation  with  either  BCMGSHygXs, BCM- 
GSHygVpr,B,  or  BCMGSHygXsVpreB (4)  and  selected with 
hygromycin  B (0.8 mg/ml, Boehringer Mannheim GmbH, Mann- 
heim, Germany) to obtain single or double transfectants. Transfec- 
tants expressing high level of transcripts spedfic for Xs and/or Vp~B 
detected by RNA dot blot were subcloned by limiting dilution. 
The establishment of Ltk-/~XsVp~0B, fibroblast Ltk- cells trans- 
fected with three genes encoding #  H chain, X5, and VmB, has 
been described previously (4). 
Preparation of mAbs Specific for As and VmB.  The/~ H chain/ 
Xs/VmB complex was purified by absorption to M41-conjugated 
Sepharose beads from culture supernatants of a fibroblast transfec- 
tant Ltk-/zXsVp,o~  which secreted a soluble form of the complex 
at a concentration of 200-300 ng/ml (4). Female Lewis rats (In- 
stitut flit Medizinische  Forshung  AG, Fiillinsdorf,  Switzerland)  were 
immunized intraperitoneally four times at 2-8-wk intervals, each 
time with 7 ~g of the complex absorbed to the beads. Sera taken 
from the animals after a fourth immunization contained antibodies 
to the complex as detected by immunoprecipitation. One of the 
animals was given a final  boost with intravenous  and intraperitoneal 
injections of 70 #g of the complex eluted from M41-conjugated 
beads with glycine-HC1  buffer (pH 2.7). 3 d after the final injec- 
tion,  spleen cells (3.2  x  105) were fused with routine  X63- 
Ag8.653 myeloma  cells (5.7 x  107) using polyethylene  glycol 1500 
(Boehringer Mannheim) and distributed at a density of 1.6  x  105 
spleen cells/well  in 1,968 microtiter wells with medium containing 
HAT and rib6 (30). Each well had several colonies of hybridoma 
in 10 d. Culture supernatants of hybridoma were initially screened 
by ELISA for reactivity to #XsVr~oB complex but not to IgM (/~K 
and/xX). Supernatants of selected cultures were further character- 
ized by cell surface staining as well as immunoprecipitation and 
cloned twice by limiting dilution. All the mAbs to X5 and Vp~B 
described here were of the IgG2a subclass and had K L chains as 
determined by the isotyping kit (Serotec, Oxford,  UK). 
Cell Labeling and Immunoprecipitation.  For biosynthetic labeling, 
cells (3-5  x  106) were cultured at 37~  for 4 h in 1 ml of methi- 
onine-free  RPMI-1640 medium or cysteine-free  RPMI-1640 medium 
(RPMI-1640 Select-Amine  kit; Gibco Laboratories) supplemented 
with  10%  dialyzed FCS and 0.3-0.5  mCi of [3SS]methionine 
(1,000 Ci/mmol; Amersham  International, Amersham,  Bucks, UK) 
or [3SS]cysteine  (1,300 Ci/mmole, Amersham) and lysed for 30 rain 
on ice in 1 ml of NP-40 lysis buffer (1% NP-40, 150 mM NaC1, 
50 mM Tris-HC1, pH 8.0, 50 mM iodoacetamide, 0.02% NAN3, 
1 mM PMSF, 2/zg/ml aprotinin, and 1 #g/ml pepstatin). In case 
of Ltk-/zXsVr~, ceils (2  x  105/0.5 ml/well) were pulsed for 10 h 
with 0.1 mCi [35S]methionine  and culture superuatants were col- 
lected. 
For cell surface labeling, cells (5  x  107) were suspended  in 1 ml 
PBS and iodinated for 40 rain at room temperature by addition 
of 50 ~1 200 mM D-glucose, 1 mCi of Nal~I (15.3 mCi l~sI/#g 
of iodine, Amersham), and 50/zl lactoperoxidase  (50 U/ml, Sigma 
Chemical Co., St. Louis, MO)/glucose oxidase (10 U/ml, Sigma 
Chemical Co.) solution, and lysed as above. 
Cell lysates and culture superuatants were precleared with pro- 
rein A-Sepharose  beads (Pharmacia, Uppsala, Sweden)  preincubated 
with normal rabbit serum. Precleared  samples were incubated with 
mAbs at 4~  for 1 h followed  by incubation with affinity-purified 
rabbit anti-rat IgG antibodies (Jackson ImmunoResearch Labora- 
tories, Inc., West Grove, PA) for 30 min and then with protein 
A-Sepharose beads for 1 h. Immunoprecipitates were washed as 
described (4), suspended in 50/zl of reducing or nonreducing 
Laemmli sample buffer, boiled for 2 rain, and subjected to SDS- 
PAGE. Gels  were stained  with Coomassie  blue for 20 min, destained 
for 4 h, soaked for 30 rain in Enlightning (New England Nuclear, 
Boston, MA) only in the case of asS-labeled samples, and dried. 
Dried gels were autoradiographed at -70~  on X-Omat AR film 
(Eastman Kodak, Rochester, NY) with intensifying screens. For 
deglycosylation  of  proteins, immunoprecipitates were resuspended 
in 20/zl elution buffer (0.5% SDS, 50 mM Tris-HC1, pH 8) and 
boiled for 2 rain, followed  by addition of 3/zl 10% octylglucoside 
(Boehringer Mannheim) and 3 #1 N-glycosidase F (PNGase F  1, 
200 U/ml; Boehringer  Mannheim) and incubation at 37~  for 18 h. 
In two-dimensional  nonreducing/reducing SDS-PAGE, precipitates 
were run in the first dimension  under nonreducing conditions  using 
a 7-15% gradient polyacrylamide  slab gel. The relevant strips were 
then cut out, incubated in Laemmli sample buffer with 20 mM 
dithiothreitol for 30 rain, and run in the second dimension on a 
7-15% gradient SDS-PAGE gel. Two-dimensional  IEF/SDS-PAGE 
and nonequilibrium pH gradient electrophoresis  (NEPHGE)/SDS- 
PAGE were performed as described (31, 32), using the ampholyte 
Pharmalyte 2D 3-10 (Pharmacia). 
Cell Su~ce Staining.  Cells  (105) were incubated with 100 #1 
of hybridoma supernatant diluted 1:1 in staining buffer (PBS, 0.2% 
BSA, 0.1% NAN3) for 30 min on ice. After three washes with 
staining buffer, cells  were incubated for 30 rain with 100/~1 of 1:100 
diluted FITC-conjugated MARK1 (mouse mAb to rat nr L chain; 
Immunotech S.A., Marseilh, France). Immunofluorescence  was ana- 
lyzed on a FACScan  |  (Becton Dickinson & Co., Mountain View, 
CA). 
Results 
Establishment of mAbs Specific for Murine As and V~s  An 
Ltk-  fibroblast (Ltk-~XsVp,,B)  transfected with the three 
1  Abbreviations used in this Faper: NEPHGE, nonequilibrium  pH gradient 
ehctrophoresis; PNGase F, N-glycosidase  F. 
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three proteins (86, 22, and 16 kD, respectively) as a complex 
(4) that can be precipitated with rat mAb M41 specific for 
mouse # H chain (Fig. 1 A, lane 2). The complex was purified 
from culture supernatant of Ltk-#)~sVp~,B cells by immuno- 
adsorption on M41-conjugated Sepharose beads and used for 
immunization of rats.  Hybridomas were prepared by fusion 
of spleen cells from an immunized rat. The initial screening 
of hybridoma supernatants was performed by ELISA using 
microtiter plates coated with either the #)~sVp~,B complex, 
IgM (/zK), or IgM (/~)~). 11 mAbs were selected which had 
reactivity to the complex, but not to IgM (/~r and/~)~) (data 
not  shown). 
7 out of the 11 mAbs precipitated #~,sVvr~ complex from 
culture supernatant of the Ltk-#XsVv~B transfectant as did 
the #  H chain-specific mAb M41 (two representative mAbs 
are shown in Fig.  1 A, lanes 3 and 4). To identify the reac- 
tivity towards antigenic determinants in the complex fur- 
ther, Ig-nonproducing myeloma X63-Ag8.653 cells transfected 
with either the ~,s gene or the Vvr~B gene alone, or with the 
two genes were employed. Five of the mAbs recognized a 
22-kD protein present in the Xs transfectant but not in the 
Vp~S transfectant, whereas two other mAbs detected a  16- 
kD protein present in the Vv~eB transfectant but not in the 
~,5 transfectant (two representatives LM34  and VP245  are 
shown in Fig. 1 B, lanes 2, 3, 5, and 6). This demonstrates 
that  the former five mAbs are specific for the Xs protein, 
whereas the latter two are specific for the Vp~B protein. For 
all subsequent experiments, two mAbs, the Xs-specific mAb 
LM34  and the Vvr~B-specific mAb VP245,  were used. 
~,s protein and Vv,~ protein were coprecipitated with each 
other by either mAb LM34 or VP245  from X63-Ag8.653 
cells  transfected with both  Xs  and Vr~s  genes (Fig.  1 B, 
lanes 8 and 9). This shows that ~,s and Vpr~B  proteins can be 
associated with each other to form a surrogate L chain even 
in the absence of# H chain. Thus, the established mAbs rec- 
ognize Xs protein or Vr~oB  protein as a single or in a form of 
VvreB/)~s surrogate L chain, or in the complex of #)~sVp~eB. 
The Synthesis and Cell Surface Expression of)is and Vw8 Pro- 
teins in Pro- and Pre- B  Cell Lines.  The synthesis of the Xs 
and Vp~e8 proteins was monitored in a panel of transformed 
pro- and pre-B cell lines,  as well as nontransformed pre-B 
cell lines,  which are thought to represent various stages  of 
B cell development in fetal liver or bone marrow (Table 1). 
Cells  were biosynthetically labeled  with  [3SS]methionine, 
and cell lysates were analyzed by immunoprecipitation with 
specific mAbs. All the cell lines tested were found to produce 
the 22 kD ~,s and the 16-kD Vp~B proteins as a complex, 
irrespective of whether they produced/~ H chain or D,JHC/x 
protein (33) or none of them (data not shown, but summa- 
rized in Table  1). 
Next we examined the expression of Xs and Vp~B proteins 
on the surface of these cell lines by flow cytometry (Fig.  2 
and Table 1). All/z H chain-producing pre-B cell lines tested 
expressed )~5 and Vp~e8 proteins together with #  H chain on 
their surface (shown for NFS5.3 in Fig.  2,  and not shown 
for others but summarized in Table l). On the other hand, 
B  cell lines WEHI231  expressing IgM(#K)  and CH-1  ex- 
pressing IgM(#X) were not stained with mAbs LM34 nor 
VP245 (Fig.  2), showing once more that the mAbs do not 
crossreact with K or )~ L chains. The two cell lines 38C13 
and B3-P8-16-1-#, which appear to be in transit from pre-B 
to B cells, expressed on the surface K L chain as well as )~s, 
Vpr~B proteins, and #  H  chains (Fig. 2 and Table 1). Proteins 
Figure  1.  Specificity  of mAbs for either Xs or VW,B protein. (/1) Culture supernatant (0.1 ml/lane) of Ltk-/L~,sVv,,B transfectant  labeled for 10 h 
with [3sS]methionine  was reacted  with rat mAbs, and immunoprecipitates  were analyzed  by 4-20% gradient SDS-PAGE  under reducing  conditions. 
Gds were soaked  in Enlightning,  dried, and autoradiographed.  Antibodies  used include:  control  mAb ('Y2a~)  (c, lane I), # H chain-specific  mAb M41 
(M, lane  2), mAb LM34 (t, lane  3), and mAb VP245 (v, lane 4). (B) X63-Ag8.653 cells  were transfected  either with Xs gene alone, Vp,,B gene alone, 
or both genes. Each transfectant  (4  x  106 cells/ml) was biosynthetically  labeled with [3sS]methionine  for 4 h and lysed  with 1% NP-40 lysis buffer. 
Detergent-soluble  lysate  was reacted  with either mAb M41 (M, lanes I, 4, and 7), mAb LM34 (t, lanes 2, 5, and 8), or mAb VP245 (v, lanes 3, 
6, and 9), and immunoprecipitates  were analyzed  by 12.5% SDS-PAGE  under reducing  conditions. 
471  Karasuyama  et al. Table  1.  Synthesis and Cell Surface Expression of V~s/As surrogate L  chain in Pro- and Pre-B Cell Lines 
Ig  gene 
Origin  of cells  rearrangements  Synthesis  Surface  expression 
Cell  line  Mouse  Tissue  Establishment  H  L  X5  VpreB  /~H  L  Xs  Vp~0B  /~H  L 
63-12  RAG-2-/-  FL  A-MuLV  G  G  +*  +  -  -  +*  +  -  - 
63-24  RAG-2-/-  FL  A-MuLV  G  G  +  +  -  -  +  +  -  - 
38B9  BALB/c  FL  A-MuLV  DJ/DJ  G  +  +  -  -  +  +  -  - 
40E1  BALB/c  FL  A-MuLV  DJ/DJ  G  +  +  -  -  +  +  -  - 
Clone  18  BDF1  FL  Stroma/IL-7  DJ/DJ  G  +  +  -  -  +  +  -  - 
PAL1  BDFt  FL  Stroma/IL-7  DJ/DJ  G  +  +  -  -  +  +  -  - 
NP  BALB/c  BM  Stroma/IL-7  DJ/DJ  G  +  +  -  -  +  +  -  - 
300-19P  NIH/Swiss  BM  A-MuLV  DJ/DJ  G  +  +  (DJC/~)  -  +  +  (DJC/~)  - 
204-1-8  BALB/c  BM  A-MuLV  R  G  +  +  -  -  +  +  -  - 
220-8  BALB/c  BM  A-MuLV  VDJ-/VDJ-  G  +  +  -  -  +  +  -  - 
28C9  BALB/c  FL  A-MuLV  VDJ*/VDJ  -  G  +  +  +  -  +  +  +  - 
204-3-1  BALB/c  BM  A-MuLV  R  G  +  +  +  -  +  +  +  - 
18-81  BALB/c  BM  A-MuLV  R  R  +  +  +  -  +  +  +  - 
70Z/3  BDFt  BM  Methyl  nitrosourea  VDJ +/DJ  R  +  +  +  -  +  +  +  - 
NFS5.3  NFS/N  Cas-2SM-MuLV  R  R  +  +  +  -  +  +  +  - 
B3-P8-16-1-#  NlH/Swiss  BM  A-MuLV  IL  R  +  +  +  ~  +  +  +  K 
38C13  C3H/eB  Dimethylbenzanthraeene  VDJ+/DJ  R  +  +  +  ~  +  +  +  K 
*  Proteins were detected by immunoprecipitation of biosynthetically labeled cell lysates with  specific mAbs. 
t  Proteins were detected by cell  surface staining. 
FL, fetal liver; BM, adult bone marrow; G, germline; R, rearranged (DJ, DHJH rearrangement, VDJ + , productive VHDsJH rearrangement, VDJ-, 
nonproductive VHDKI~ rearrangement). 
Xs and Vp,~B were also detectable on the surface of the 300- 
19P cell line which has D,J. rearrangements in both alleles 
of the IgH locus and produces a D,J.C/~ protein (Fig.  2). 
The level of expression of Xs and VproB was lower compared 
with other pre-B cell lines that express a full-size # H chain. 
Cell surface expression of Xs and Vpr~B proteins was also 
observed on precursor B cell lines that could not, or did not 
yet express D.J.C# or normal #  H  chains. Such cell lines 
could either be transformed with A-MuLV (38B9 and 40E1 
cells) or could be growing on stromal cells in the presence 
of IL-7 (Clone 18, PAL1, and NP) as shown in Fig. 2 and 
Table 1. These cell lines have Ig L chain loci in germline 
configuration and D,J, rearrangements on both alleles of the 
IgH chain locus, but produce no D~.C# proteins (34). The 
surface expression  of Xs and Vvr~S proteins without /~ H 
chain was also detectable on two pro-B cell lines 63-12 and 
63-24 derived from the fetal liver of mice in which the RAG-2 
gene had been disrupted by targeted integration on both chro- 
mosomes (Fig. 2 and Table 1). These cell lines have been shown 
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Figure  2.  FACS  |  analysis of Vr~=B/Xs sur- 
rogate L  chains expressed on pro- and pre-B 
cell lines detected by specific mAbs. Cells were 
incubated first with either control mAb, #  H 
chain-specific  mAb  M41,  Xs-specific  mAb 
LM34,  or  Vm=s-specific  mAb  VP245,  and 
then with FITC-conjugated MARK1. Immuno- 
fluoR~.ence was analyzed on a FACScan  |  (Un- 
shaded histogram)  Control  staining; (shaded 
histograms) stainings with M41, LM34, and 
VP~5. In the case of 38C13 cells, staining with 
K  L chain-specific mAb 187.1 is shown as well. 
NFS5.3,  300-19P, 38B9, and 63-12 cell lines 
were all negative for surface L  chain. 
472  Glycoproteins Associated with Vp~B/)XS Surrogate L  Chain of producing any Ig chain (13). We condude that the Xs and 
Vp~ proteins can be deposited on the surface membrane not 
only in #  H  chain-positive  precursor B cell lines,  but also 
in progenitor and precursor B cell lines that do not,  or do 
not yet express #  H  chains. 
Association if)is and  V~B Proteins on the Surface of /~ H 
Chain-negative Precursor  B Cell Lines.  To identify a possible 
partner(s)  of the  ~,s and Vr~oB proteins  which might  carry 
them onto the surface of the/z H chain-negative progenitors 
and precursors, the pro-B cell lines 63-12 and the early pre-B 
cell line 38B9 were surface labeled with lzsI, and the cell ly- 
sates were subjected to immunopredpitation with the specific 
mAbs (Fig. 3, A and B, respectively). Whereas no # H chain 
was detectable,  as expected,  the 22-kD  )~s protein  and the 
16-kD Vr~a3 protein were coprecipitated with each other by 
either LM34 or VP245 (Fig. 3, A  and B, lanes 3 and 4). This 
indicates that •s  and VproB proteins are associated with each 
other to form a surrogate L chain in the absence of# H chain 
on the cell surface. 
The ~s protein  in association with #  H  chain and Vp~B 
protein expressed on the surface of the #  H  chain-positive 
pre-B cell line NFS5.3 has always been found to be poorly 
iodinated so that it could hardly be seen in autoradiography 
(Fig.  3  C,  lanes 2-4),  as was also noted by others  (8).  In 
contrast,  the )~s protein was iodinated fairly well on the # 
H  chain-negative cell lines (Fig.  3, A  and B, lanes 3 and 4). 
This indicates a differential accessibility of tyrosine residues 
within the Xs protein, which is apparently dependent on the 
presence or absence of # H  chain. This observation is consis- 
tent  with  a recent  report by others  (9). 
The band of 22 kD corresponding to )~s protein was not 
detectable in the nonreducing gels (in Fig. 3 A, lanes 7 and 
8 and Fig. 3 B, lanes 10 and II), suggesting that Xs protein 
exists in disulfide-linked complexes on the cell surface. There- 
fore, the immunoprecipitates with mAb LM34 were further 
analyzed by two-dimensional SDS-PAGE, in the first dimen- 
sion under nonreducing conditions, and then in the second 
dimension under reducing conditions.  Monomeric proteins 
as well as oligomeric proteins not linked by disulfide bonds 
will migrate identically in both dimensions and can thus be 
found on the diagonal of gels.  In contrast, a disulfide-linked 
oligomer will migrate  as a complex in the first dimension 
and then will dissociate into separate subunits in the second 
dimension, therefore appearing as spots below the diagonal. 
VpreB protein  was found on  the diagonal  whereas most  of 
)~s  protein  was  detected below  the  diagonal  (Fig.  4,  A). 
Some of X5 protein  was detectable as an  off-diagonal  spot 
of 38 kD in first dimension and of 22 kD in second dimen- 
sion. There was no off-diagonal spot detectable above or below 
this  )~s  spot.  The  rest  of the  ~,s  proteins  were  found  in 
poorly defined complexes of higher tool wt, making a "streak" 
rather  than  distinct  spots. 
The immunoprecipitates with LM34 were further charac- 
terized by two-dimensional  NEPHGE/SDS-PAGE  analysis 
(Fig.  5 A).  The )~s protein migrated with a molecular mass 
of 22 kD and at a fairly basic pH. There was no other spot 
of 22 kD detectable besides ~,s protein.  These results  sug- 
gested two possibilities: (a) the Xs protein in the off-diago- 
nal spot is disulfide-linked  to a protein with  the same tool 
wt  and  the  same  charge,  most  likely  to  itself to  form  a 
homodimer;  and (b) the )~s protein is disulfide-linked to an- 
other protein that  is hardly labeled with  l~sI. To identify a 
disulfide-linked partner of Xs protein,  cells were biosynthet- 
ically labeled with [3SS]cysteine, and the immunoprecipitates 
Figure 3.  Identification  and characterization of molecules associated with Vpr~/)~S surrogate L chain on the cell surface. Cells (63-12 in A, 38B9 
in B, and NFS5.3 in C) were surface  labeled  with 1~I and lysed  with 1% NP-40  lysis buffer. Detergent-soluble  lysates  (1.5 x  107 cells equivalent/lane 
in A and B, and 107 cells equivalent/lane in C) were reacted with either control mAb (c; lanes I and 5 in A and C, lanes 1 and 8 in B), mAb M41 
(M; lanes 2 and 6 in A and C, lanes 2 and 9 in B), mAb LM34 (t; lanes 3 and 7 in A and C, lanes 3 and 10 in B), mAb VP245 (v; lanes 4 and 
8 in A and C, lanes 4 and 11 in B), LPAM-1 (murine VLA-4ot)-specific  mAb R1-2 (v; lanes 5 and 12 in B), CD45-specific  mAb MI/9.3.4 (B; lanes 
6 and I3 in B), or MHC class I-specific  mAb Strl0 (s; lanes 7 and 14 in B). Immunoprecipitates were analyzed  by 7-15% gradient SDS-PAGE  under 
reducing conditions (l~; lanes I-4 in A and C, lanes 1-7 in B) or under nonreducing conditions (NR; lanes 5-8 in A and C, lanes 8-16 in B). In B, 
lanes 15 and 16, the immunoprecipitates with mAb LM34 were incubated with (lane 16) or without (lane 15) PNGase F, followed  by SDS-PAGE 
under nonreducing conditions. 
473  Karasuyama  et al. Figure  4.  Analysis of the complex with V~/Xs  surrogate L chain by nonreducing/reducing  two-dimensional  SDS-PAGE. The/~ H  chain-nega- 
tive pre-B cell line 38B9 was surface labeled with 12sI (,4) or biosynthetically labeled with [3sS]cysteine (B). NP-40 lysates (3  x  107 cells equivalent 
in A  and 3  x  106 cells equivalent in B) were reacted with Xs-specific mAb LM34.  Immunoprecipitates  were run in the first dimension (horizontal 
axis) under nonreducing  conditions  on 7-15% gradient  SDS-PAGE gel, then in second dimension  (vertical axis) under reducing conditions  on 7-15% 
gradient  SDS-PAGE gel.  Immunoprecipitation  with Vp~eB-specific  mAb VP245  gave comparable pictures  (data not  shown). 
with LM34 were analyzed by two-dimensional nonreducing- 
reducing SDS-PAGE  (Fig.  4 B).  In contrast  to cell  surface 
Xs proteins labeled with 12sI, the majority  of Xs proteins  la- 
beled with [3SS]cysteine were found on the diagonal, indi- 
cating that they were not in disulfide-linked  complexes.  On 
the other hand, a small fraction  of Xs proteins  was detect- 
able below the diagonal as a spot and a streak in the same 
position as observed in the 12SI-labeled material.  There was 
again no off-diagonal spot detectable above or below the off- 
diagonal spot of Xs. This is consistent with the first possi- 
bility suggested  above, that is, that the Xs protein of the off- 
diagonal spot is a disulfide-linked homodimer. Similar results 
were obtained when cells were labeled with [3SS]methionine 
(data not shown). Thus, some of the ks protein expressed 
on  the  cell  surface  appears  to  exist  as  a  disulfideqinked 
homodimer, whereas most of the ~,s protein  was found in 
poorly defined complexes with higher mol wt under the con- 
dition employed in this study. 
Proteins Associated with VmB/As Surrogate L  Chain on the 
Surface of  /~ H Chain-negative Precursor  B Cell Lines.  A com- 
plex of proteins  of 200,  130,  and 105  kD,  and several be- 
tween 65 and 35 kD, was found coprecipitated with Vp~B/Xs 
Figure  5.  Analysis of the com- 
plex  with  Vp~/Xs  surrogate  L 
chain  by  two-dimensional  NEP- 
HGE/SDS-PAGE  and  IEF/SDS- 
PAGE.  The  #  H  chain-negative 
pre-B cell line 38B9 was surface la- 
beled with 12si, and NP-40 lysates 
(4  x  10  ~  cells equivalent/precipita- 
tion) were reacted  with mAb LM34. 
Immunoprecipitates were separated 
by charge  in  the  first  dimension 
(hor/zxmtal  ax/s) in NEPHGE gel (.4) 
or in IEF gel  (B) under reducing 
conditions,  then in second dimen- 
sion (vertical axis) separated by size 
in 7-15% gradient SDS-PAGE gel 
under reducing conditions. (I) p130; 
(2) Xs protein;  and (3) Vms pro- 
tein.  Note  that  the Us protein  is 
fairly basic as seen in A  so that it 
runs out of the IEF gd under the 
condition used in B. 
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12 and 38B9 (Fig. 3 A, lanes 3, 4, 7, and 8; and Fig. 3 B, 
lanes 3, 4, I0, and 11). These proteins were not detectable 
in immunoprecipitates with LPAM-1  (murine VLA-4o  0- 
specific, CD45-specific  or MHC class I-specific mAbs (Fig. 
3 B, lanes 5-7 and 12-14).  Therefore, the coprecipitation of 
these proteins is specific for Vp~B/~,s surrogate L chain. The 
strongly labeled 130-kD protein (pD0) was detectable on the 
diagonal  when  analyzed  by  two-dimensional  non- 
reducing-reducing SDS-PAGE (Fig. 4 A). This indicates that 
p130 is associated noncovalently with Vp~/Xs surrogate L 
chain on the cell surface. The p130 migrated in pI 5.8 on 
two-dimensional IEF/SDS-PAGE  (Fig. 5 B). The p130 was 
not detectable on the surface of # H chain-positive NFS5.3 
cells  as coprecipitated with/~,sVp~B complex (Fig.  3  C, 
lanes 2-4  and 6-8). 
The intensity in autoradiography of the additional pro- 
teins (200, 105, and 65-35 kD) coprecipitated with the sur- 
rogate L chain varied in different preparations, compared with 
that of p130,  Xs, and Vp~B proteins. It suggests that these 
molecules may associate loosely with p130 and surrogate L 
chain. The 200-kD protein and most of the proteins around 
35-65 kD were found on the diagonal in the nonreducing/ 
reducing two-dimensional gel (Fig. 4 A), indicating that they 
are bound noncovalently to the p130/V~/Xs complex. The 
50-kD protein migrated faster under non.reducing conditions 
than under reducing conditions (Fig. 3 B, compare lanes 3 
and  10),  finding itself above  the  diagonal  on  the  two- 
dimensional gel (Fig.  4 A). This suggests that the 50-kD 
protein may contain an intramolecular disulfide bond(s). The 
105-kD protein appears to form a disulfide-linked homodimer 
with an apparent mol mass of 200 kD, since it was detectable 
as one single off-diagonal spot on the nonreducing/reducing 
two-dimensional gel (Fig. 4 A). Though some materials be- 
tween 65 and 50 kD appeared to be below the diagonal (Fig. 
4 A),  it  remains to be investigated with better methods 
whether they are disulfide-linked to each other or to the ~,s 
protein or to other proteins. In two-dimensional NEPHGE/ 
SDS-PAGE (Fig. 5 A) and IEF/SDS-PAGE  analysis (Fig.  5 
B), proteins around 45-65  kD resolved  into several spots 
around pI 5.4-6.0, indicating considerable structural hetero- 
geneity of these surrogate L chain-associated proteins. 
Most Proteins Associated with Surrogate L  Chain on the Sur- 
face of  /.z H Chain-negative Precursor B Cell Lines Are Glycopro- 
tein.  The treatment of the immunoprecipitates  with PNGase 
F, as expected, did not change the apparent mol wt of the 
Vpr~B and Xs proteins. However, it reduced the apparent mol 
wt of the 200-kD protein (to 190 kD), the p130 (to 100 kD), 
and the proteins between 45 and 55 kD (to 35-45 kD) as 
shown in Fig. 3 B, lanes 15 and I6. The two-dimensional 
nonreducing/reducing SDS-PAGE analysis revealed that the 
105-kD subunit of disulfide-linked homodimer reduced its 
apparent mol wt to 90 kD by treatment with PNGase F (data 
not shown). We conclude that most of the proteins associated 
with surrogate L chain on ~ H chain-negative precursor B 
cell lines contain N-linked oligosaccharides  and are, there- 
fore,  glycoproteins. 
Discussion 
All/z H chain-produdng transformed pre-B cell lines tested 
so far express the Vp~,B/~,s surrogate L chain on the surface. 
We show that the 16-kD protein, also called ~, is detectable 
by Vpr,S-specific mAbs. These mAbs, in fact, coprecipitate 
k5  protein  and  #  H  chain.  This  finally  proves  that  the 
product of the Vp~ gene is expressed on the surface of pre-B 
cells, and that it is the 16-kD protein described previously 
(8, 9, 35). Vpr,B protein is also detectable on the surface of 
300-19P  cells in association  with D.J,C#  protein and ~,s. 
This indicates that the molecular contacts between V~  and 
Xs are strong enough to allow the formation of a trimolecu- 
lar complex, even though potential contact sites between 
Vp~~  and VH are missing. 
It is intriguing that Vr~B/Xs surrogate L chains are de- 
tectable without/~ H chain on the cell surface of pro-B cell 
lines where all Ig loci are in the germline configuration, as 
well as on the surface of pre-B cell lines where Ig H  chain 
loci are DHJH rearranged in reading flames that do not allow 
the expression  of D,J,C#  protein. This indicates  that the 
synthesis of Vp~es/Xs surrogate L chain does not necessarily 
require the rearrangements of Ig H chain loci. Although this 
is true for transformed cell lines or for long-term prolifer- 
ating stromal cell/IL-7-dependent cell lines, it will have to 
be investigated whether normal precursor cells ex vivo show 
the same pattern of expression  of surrogate L chain. 
Misener et al.  (9) reported that the complex of Xs pro- 
tein and a 16-kD protein (p16), now identified as Vp~,B, was 
expressed on the surface of/~ H chain-negative A-MuLV-trans- 
formed pre-B cell lines carrying two VHD,d.-rearranged  al- 
leles. However, in their study, no other molecules were found 
to be specifically associated with the )~s/p16 complex (9). 
Since neither Xs nor Vp~ proteins have typical hydrophobic 
transmembrane portions, the question arises of how surrogate 
L chains could be deposited in the surface membrane. 
In this study, we have identified some of the candidate pro- 
teins that might carry the surrogate L chain onto the surface 
of pro-B and early pre-B cells. Most consistently detected and 
most strongly 12SI-labeled  was a 130-kD protein with pI 5.8 
in the protein complex coprecipitated with Vpr,B/Xs surro- 
gate L chain from the # H chain-negative cell lines. It was 
not detectable in the immunoprecipitates with #  H  chain/ 
Vp~,B/~,s complex from the #  H  chain-positive cell lines. 
The association  of the p130 and the Vp~/Xs surrogate L 
chain was found to be noncovalent. The treatment with 
PNGase F revealed that the p130 is a N-linked glycoprotein 
with a core protein of around 100 kD. This makes it unlikely 
that p130 is identical to CD43 (leukosialin), which is expressed 
at a very early stage of differentiation in the case of B-lineage 
cells and downregulated upon V,D~d, rearrangement (36). 
CD43 is a heavily sialylated O-linked glycoprotein with a 
protein core of 38 kD and displays an apparent molecular 
mass of 90-150 kD, depending on cell types. The sequence 
of the cDNA of routine CD43 predicts only one possible 
N-linked glycosylation site (37). PNGase F treatment has little 
if any effect on the size of CD43 (38).  In addition, CD43 
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iodinated with lactoperoxidase, whereas the p130 is well io- 
dinated. 
p130 is also unlikely to be the BP-1/6C3 aminopeptidase. 
The BP-1/6C3 antigen, a disulfide-linked  homodimer  formed 
by 140-kD N-linked glycoprotein  subunits  with a protein 
backbone of 110 kD, also has been shown to be expressed 
on early B-lineage ceils (39, 40). However, the cell surface 
expression of the BP-1/6C3 and that of p130 do not corre- 
late to each other. The 38B9 pre-B cell line displays p130 but 
not the BP-1/6C3 on the surface (40). Moreover, p130 is not 
a disulfide-linked homodimer. Thus, p130 does not appear 
to be the BP-1/6C3  antigen. 
CD22  is  a B-lineage-specific N-linked glycoprotein  of 
130/140 kD in humans and 150 kD in mice with a protein 
core of 100-110 kD. It has been suggested that CD22 plays 
a role in B cell-B cell, B cell-monocyte, and B cell-T cell 
interaction (41-43). We have employed the mAb specific for 
murine CD22 to examine whether surrogate  L chain was 
coprecipitated with CD22. However, the mAb precipitated 
a 150-kD protein without Vpr0B/hs surrogate L chain from 
the 63-12 pro-B call line, indicating that the p130 is not CD22 
(data not shown). It remains to be determined whether the 
p130 is identical to other known N-linked glycoproteins with 
a molecular mass of ~130 kD expressed in B-lineage cells, 
such as CD21 (molecular mass 140 kD with a 120-kD core 
protein in humans) (41), the IL-6 signal transducer gp 130 
(molecular mass 130 kD with a 100-kD core protein)  (44), 
and the common fl chain of IL-3R, IL-5R, and GM-CSF-R 
(45). 
Besides p130, several glycoproteins (200, 105, and 65-35 
kD) were found coprecipitated with surrogate L chain, even 
though they appeared to be bound less strongly to surrogate 
L chain (or to p130). In this study, 1% NP-40 was used to 
solubilize membrane proteins. It remains to be investigated 
how different protocols of cell lysis (variations of detergent, 
salt, pH,  etc.) might change the composition of the non- 
covalently associated protein complex. 
When the immunoprecipitates  with Vpr,B- or ~,s-specific 
mAbs were prepared from surface-iodinated/z H chain-nega- 
tive precursor B cell lines and analyzed by SDS-PAGE under 
nonreducing conditions, a substantial amount of radioactivity 
was found at the top of gels (Fig. 3 A, lanes 7 and 8, Fig. 
3 B, lanes 10 and 11). Whereas p130 and VmB protein gave 
distinct bands as observed under reducing condition,  hs pro- 
tein never showed up itself as distinct bands under nonreducing 
conditions. The nonreducing/reducing two-dimensional SDS- 
PAGE analysis revealed that  some ~,s  protein exists  as  a 
disulfide-linked homodimer. However,  the majority of )~5 
protein was found in poorly defined complexes with higher 
mol wt. Moreover, a significant fraction of these complexes 
was trapped in the first gel and did not enter the second gel 
of two-dimensional SDS-PAGE. Such "aggregates" were also 
observed in the/~XsVr,eB complex precipitated from NFSS.3 
cells (Fig. 3 C, top, lanes 6-8). It has been reported that TCR 
fl chain was expressed in the absence of any other known 
TCR. chains on the surface of immature T cells (46). It is 
interesting that substantial amounts of the TCR fl chain were 
found in poorly defined high mol wt complexes when the 
immunoprecipitates  were analyzed under nonreducing con- 
dition by SDS-PAGE. It needs to be analyzed  by better methods 
which resolve these  aggregates  of ~,5 protein in order to 
darffy how many of these complexes  are really disulfide  bonded 
and which proteins participate in such covalent bonds. It also 
remains  to be investigated whether these macromolecular 
forms represent naturally occurring complexes or whether 
they are artificially generated during preparation of samples. 
In this  study, we have shown the surface deposition  of 
Vr,eB/Xs surrogate L chain in association with the glycopro- 
tein complexes in/z H chain-negative precursor B cell lines. 
This suggests that the surrogate L chain may function as a 
receptor on the cell surface even before the association with 
/~ H chain in early precursor B cells. The mAbs established 
in this study should be useful in elucidating  the structure 
of Ig-like receptor molecules expressed in the early stage of 
normal B cell differentiation. We are in the process of analyzing 
the progenitor and precursor B cell compartments in fetal 
liver and bone marrow of normal and mutant mice to see 
whether the pattern of surrogate L chain expression and the 
association with the newly identified partners is the same in 
normal cells ex vivo. The mAbs may also be useful in our 
search for a possible ligand(s) of the surrogate L chain com- 
plex and in the characterization of developmentally regulated 
signal transduction in different precursor B cell subpopulations. 
They should also prove useful in identifying and purifying 
progenitor and precursor  B cells from different lymphoid 
organs of mice at different times in ontogeny, and in iden- 
tiffing possible defects in B cell development that might arise 
as a consequence of an abnormal expression of surrogate L 
chain. 
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